Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.
Journal of Clinical Oncology.
Times cited: 242
Activated extracellular signal-regulated kinases: Association with epidermal growth factor receptor/transforming growth factor α expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.
Times cited: 259